3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
4
Ovarian Neoplasms
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Multiple Myeloma
2
Motor Activity
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Smoking Cessation
1
Quality of Life
1
Postoperative Complications
1
Patient Compliance
1
Neoplasms
1
Metabolic Syndrome
1
Localized Prostate Carcinoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypothalamic Neoplasms
1
Healthy Diet
1
Glioma
1
Gastrointestinal Neoplasms
1
Interventions
Dexamethasone
17
Lenalidomide
15
Bortezomib
12
Cyclophosphamide
7
fludarabine
6
carfilzomib
6
Melphalan
6
daratumumab
5
Calcium Dobesilate
5
pomalidomide
3
gamma-Globulins
3
fludarabine phosphate
3
belantamab mafodotin
3
Whole-Body Irradiation
3
Trimethoprim, Sulfamethoxazole Drug Combination
3
Tacrolimus
3
Mycophenolic Acid
3
isatuximab
2
elotuzumab
2
Sirolimus
2
Prednisone
2
Immunoglobulins, Intravenous
2
Granulocyte Colony-Stimulating Factor
2
Etoposide
2
Ciprofloxacin
2
Amoxicillin-Potassium Clavulanate Combination
2
venetoclax
1
thymoglobulin
1
siltuximab
1
poly ICLC
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Diet Therapy
×
1 year
×
Clear all
No trials found.